查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1779225

纖維蛋白密封劑市場－全球產業規模、佔有率、趨勢、機會和預測，按產品（液體形式、貼片）、最終用戶（門診手術中心、醫院、專科診所）、按地區和競爭細分，2020-2030 年

Fibrin Sealant Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product (Liquid Form, Patch), By End User (Ambulatory Surgical Centers, Hospitals, Specialty Clinics), By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球纖維蛋白密封劑市值為 13.2 億美元，預計到 2030 年將達到 18.6 億美元，複合年成長率為 6.09%。纖維蛋白密封劑市場已成為現代外科手術和傷口管理的重要組成部分，在不斷發展的醫療技術領域中發揮關鍵作用。纖維蛋白密封劑，通常稱為纖維蛋白膠，是一種止血劑，用於促進血液凝固和密封手術期間和手術後傷口。隨著全球外科手術的增加，人口老化、慢性病病例增加和創傷發生率上升，對纖維蛋白密封劑的需求持續成長。該市場的主要驅動力是向微創手術的轉變，這需要能夠精確、快速起效和有效傷口閉合的工具。纖維蛋白密封劑在這些手術中受到高度重視，因為它們易於使用、具有生物相容性，並且能夠顯著減少術後併發症。外科醫生不僅在計劃手術中依賴它們，而且在創傷或事故等緊急情況下也依賴它們，在這些情況下，快速封閉傷口和控制出血至關重要。

市場概覽
預測期 2026-2030
2024年市場規模 13.2億美元
2030年市場規模 18.6億美元
2025-2030 年複合年成長率 6.09%
成長最快的領域 液體
最大的市場 亞太地區

然而，儘管纖維蛋白封閉劑具有廣泛的臨床益處，但也面臨一些限制。優質封閉劑的高昂成本可能成為其推廣應用的障礙，尤其是在發展中國家或預算有限的醫療保健系統。由於許多封閉劑源自人體血漿，其疾病傳播風險雖然微乎其微，但值得關注，這引發了人們對其長期安全性的擔憂。

關鍵市場促進因素

纖維蛋白密封劑在顯微外科手術和植入部位皮瓣閉合的新興應用是纖維蛋白密封劑市場成長的主要因素

主要市場挑戰

纖維蛋白密封劑成本高

主要市場趨勢

政府資助和醫療品質的改善

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球纖維蛋白密封劑市場的影響

第5章：全球纖維蛋白密封劑市場展望

  • 市場規模和預測
    • 按價值和數量
  • 市場佔有率和預測
    • 依類型（液體劑型、貼片）
    • 按最終使用者（門診手術中心、醫院、專科診所）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：亞太地區纖維蛋白密封劑市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第7章：歐洲纖維蛋白密封劑市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第8章：北美纖維蛋白密封劑市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第9章：南美洲纖維蛋白密封劑市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲纖維蛋白密封劑市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 土耳其
    • 埃及

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球纖維蛋白密封劑市場：SWOT 分析

第 14 章：定價分析

第 15 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代能源的威脅

第 16 章： 大環境分析

第 17 章：競爭格局

  • Johnson and Johnson
  • Baxter International Inc.
  • Nordson Corporation (Nordson Medical)
  • Corza Health Inc
  • Becton Dickinson and Company
  • CSL Behring LLC
  • Grifols SA
  • Shanghai RAAS Blood Products Co., Ltd.
  • Vivostat A/S
  • Hemarus Therapeutics Ltd.

第 18 章：策略建議

第19章調查會社について,免責事項

簡介目錄
Product Code: 18924

Global Fibrin Sealant Market was valued at USD 1.32 Billion in 2024 and is expected to reach USD 1.86 Billion by 2030 with a CAGR of 6.09%. The fibrin sealant market has become an essential component of modern surgical procedures and wound management, playing a pivotal role in the evolving landscape of medical technology. Fibrin sealants, commonly referred to as fibrin glues, are hemostatic agents used to promote blood clotting and seal wounds during and after surgeries. With the global increase in surgical procedures, fueled by an aging population, rising cases of chronic diseases, and higher rates of trauma-the demand for fibrin sealants continues to grow. The key drivers of this market is the shift toward minimally invasive surgeries, which require tools that offer precision, rapid action, and effective wound closure. Fibrin sealants are highly valued in such procedures due to their ease of application, biocompatibility, and ability to significantly reduce post-operative complications. Surgeons rely on them not only in planned operations but also in emergency settings like trauma or accident cases, where quick wound sealing and bleeding control are critical.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.32 Billion
Market Size 2030USD 1.86 Billion
CAGR 2025-20306.09%
Fastest Growing SegmentLiquid
Largest MarketAsia Pacific

However, despite their widespread clinical benefits, fibrin sealants face certain limitations. The high cost of quality sealants can be a barrier to adoption, especially in developing countries or healthcare systems with limited budgets. Since many sealants are derived from human plasma, there is a minimal yet notable risk of disease transmission, prompting concerns about long-term safety.

Key Market Drivers

Emerging Applications of Fibrin Sealant in Microsurgery and Implant Site Flap Closure is Major Factor for Fibrin Sealant Market Growth

The global fibrin sealant market is experiencing substantial growth, primarily driven by the emerging applications of fibrin sealant in microsurgery and implant site flap closure. Fibrin sealant, also known as tissue glue or surgical glue, is a biocompatible adhesive derived from human plasma proteins. It has been widely used in various surgical procedures for hemostasis and tissue sealing. Microsurgery is a highly specialized field that involves intricate procedures on very small structures, often using high-powered microscopes. Fibrin sealant has found emerging applications in microsurgery due to its ability to provide precise and controlled tissue adhesion.

In microsurgical applications, the use of fibrin sealant offers several advantages, including reduced operative time, minimal tissue trauma, and improved postoperative recovery. It allows surgeons to achieve hemostasis and close tissues with high precision. Fibrin sealant is increasingly utilized in implant dentistry for site flap closure during dental implant procedures. It plays a crucial role in securing flaps over implant sites, ensuring proper healing and osseointegration. The success of microsurgical and implant procedures heavily relies on the choice of adhesive. Surgeons demand reliable, biocompatible adhesives that can securely close tissues and promote effective healing without causing adverse reactions.

Fibrin sealant is known for its versatility. It can be used in various surgical specialties, including neurosurgery, ophthalmology, plastic surgery, and more, making it a valuable tool in the medical field. In microsurgery and implant site flap closure, precision and safety are paramount. Fibrin sealant provides the controlled and localized tissue adhesion required for successful outcomes while minimizing the risk of complications. Ongoing research and development efforts in the field of fibrin sealant have led to advanced formulations that offer improved adhesion strength, hemostatic properties, and biocompatibility. These advancements contribute to its growing adoption in microsurgery and implant dentistry. The increasing demand for precise and effective tissue adhesives in microsurgery and implant procedures is driving the need for specialized fibrin sealant products. Surgeons and healthcare professionals seek advanced solutions to enhance surgical outcomes.

The global fibrin sealant market is experiencing robust growth, primarily driven by the emerging applications of fibrin sealant in microsurgery and implant site flap closure. Fibrin sealant has become an essential tool in achieving secure tissue adhesion and promoting healing in delicate surgical procedures. As the awareness of its benefits in microsurgery and implant dentistry continues to grow, the market for fibrin sealant is expected to thrive. Manufacturers and suppliers in this market must remain at the forefront of technology and innovation to meet the evolving demands of surgeons and healthcare professionals, ensuring continued growth and improved surgical outcomes worldwide.

Key Market Challenges

High Cost of Fibrin Sealants

The high cost of fibrin sealants represents a substantial obstacle to the growth of the global Fibrin Sealant market. Fibrin sealants are biologically derived adhesives used in surgical procedures to facilitate hemostasis, tissue sealing, and wound closure. Their effectiveness and safety have made them invaluable in various surgical applications, including cardiovascular, orthopedic, and general surgery. However, the production and processing of fibrin sealants involves complex biotechnological processes and stringent quality control, resulting in elevated production costs.

The high cost of fibrin sealants can strain healthcare budgets, deter some healthcare facilities from adopting these products, and limit market growth potential. Additionally, affordability concerns can lead to a preference for alternative hemostatic and tissue sealing solutions, further hampering market expansion.

To address this challenge and stimulate growth in the Fibrin Sealant market, manufacturers must explore strategies to optimize production processes, improve cost-efficiency, and collaborate with healthcare providers to showcase the long-term benefits and cost-effectiveness of fibrin sealant use. By making these vital surgical aids more accessible, the market can continue to advance in the field of medical procedures and surgical interventions.

Key Market Trends

Government Funding and Improvement in the Quality of Healthcare

Advancements in bonding technologies are a fundamental trend driving the growth of the global Fibrin Sealant market. As industries continue to evolve, there is a growing demand for Fibrin Sealant that offer improved bonding capabilities, versatility, and efficiency. These advancements are not only transforming traditional bonding processes but also expanding the applications of Fibrin Sealant across various sectors.

The development of innovative bonding technologies includes the formulation of adhesive products with enhanced chemical compositions, allowing them to bond a wider range of plastic substrates effectively. Additionally, improvements in curing mechanisms, such as UV curing and cyanoacrylate technology, have accelerated bonding speeds and enhanced the overall performance of Fibrin Sealant.

These advancements are particularly crucial in industries like automotive, electronics, and medical devices, where plastic components play a significant role. As manufacturers seek reliable, high-performance bonding solutions to improve product quality and assembly efficiency, the global Fibrin Sealant market is poised for substantial growth. Companies that invest in cutting-edge bonding technologies and adapt to evolving industry demands are well-positioned to capitalize on this transformative trend.

Key Market Players

  • Johnson and Johnson
  • Baxter International Inc.
  • Nordson Corporation (Nordson Medical)
  • Corza Health Inc
  • Becton Dickinson and Company
  • CSL Behring LLC
  • Grifols SA
  • Shanghai RAAS Blood Products Co., Ltd.
  • Vivostat A/S
  • Hemarus Therapeutics Ltd

Report Scope:

In this report, the Global Fibrin Sealant Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fibrin Sealant Market, By Type:

  • Liquid Form
  • Patch

Fibrin Sealant Market, By End User:

  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics

Fibrin Sealant Market, By Region:

  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Turkiye
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fibrin Sealant Market.

Available Customizations:

Global Fibrin Sealant market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Fibrin Sealant Market

5. Global Fibrin Sealant Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Liquid Form, Patch)
    • 5.2.2. By End User (Ambulatory Surgical Centers, Hospitals, Specialty Clinics)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. Asia Pacific Fibrin Sealant Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. Asia Pacific: Country Analysis
    • 6.3.1. China Fibrin Sealant Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. India Fibrin Sealant Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Australia Fibrin Sealant Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User
    • 6.3.4. Japan Fibrin Sealant Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value & Volume
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By End User
    • 6.3.5. South Korea Fibrin Sealant Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value & Volume
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By End User

7. Europe Fibrin Sealant Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Fibrin Sealant Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Fibrin Sealant Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. Spain Fibrin Sealant Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Fibrin Sealant Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. United Kingdom Fibrin Sealant Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. North America Fibrin Sealant Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Fibrin Sealant Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. Mexico Fibrin Sealant Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Canada Fibrin Sealant Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User

9. South America Fibrin Sealant Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Fibrin Sealant Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Fibrin Sealant Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Fibrin Sealant Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Fibrin Sealant Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1.By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1.By Type
    • 10.2.2.By End User
    • 10.2.3.By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Fibrin Sealant Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Fibrin Sealant Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Fibrin Sealant Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User
    • 10.3.4. Kuwait Fibrin Sealant Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value & Volume
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By End User
    • 10.3.5. Turkiye Fibrin Sealant Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value & Volume
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Type
        • 10.3.5.2.2. By End User
    • 10.3.6. Egypt Fibrin Sealant Market Outlook
      • 10.3.6.1. Market Size & Forecast
        • 10.3.6.1.1. By Value & Volume
      • 10.3.6.2. Market Share & Forecast
        • 10.3.6.2.1. By Type
        • 10.3.6.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends and Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Fibrin Sealant Market: SWOT Analysis

14. Pricing Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Sources

16. PESTLE Analysis

17. Competitive Landscape

  • 17.1. Johnson and Johnson
    • 17.1.1.Business Overview
    • 17.1.2.Company Snapshot
    • 17.1.3.Products & Services
    • 17.1.4.Financials (In case of listed companies)
    • 17.1.5.Recent Developments
    • 17.1.6.SWOT Analysis
  • 17.2. Baxter International Inc.
  • 17.3. Nordson Corporation (Nordson Medical)
  • 17.4. Corza Health Inc
  • 17.5. Becton Dickinson and Company
  • 17.6. CSL Behring LLC
  • 17.7. Grifols SA
  • 17.8. Shanghai RAAS Blood Products Co., Ltd.
  • 17.9. Vivostat A/S
  • 17.10. Hemarus Therapeutics Ltd.

18. Strategic Recommendations

19. About us & Disclaimer